Comparative economic impact of intravenous versus subcutaneous administration of rituximab in patients with Non-Hodgkin's lymphoma

Please use this identifier to cite or link to this item: https://hdl.handle.net/10216/154764

Full metadata record

DC Field	Value	Language
dc.creator	Ana Rita Rolim Farinha Marques
dc.date.accessioned	2025-11-14T11:18:18Z	-
dc.date.available	2025-11-14T11:18:18Z	-
dc.date.issued	2023-11-14
dc.date.submitted	2023-09-11
dc.identifier.other	sigarra:648919
dc.identifier.uri	https://hdl.handle.net/10216/154764	-
dc.language.iso	por
dc.rights	restrictedAccess
dc.subject	Economia e gestão
dc.subject	Economics and Business
dc.title	Comparative economic impact of intravenous versus subcutaneous administration of rituximab in patients with Non-Hodgkin's lymphoma
dc.type	Relatório de Projeto
dc.contributor.uporto	Faculdade de Economia
dc.identifier.doi	10.34626/wjxa-2666
dc.identifier.tid	203554558
dc.subject.fos	Ciências sociais::Economia e gestão
dc.subject.fos	Social sciences::Economics and Business
thesis.degree.discipline	Mestrado em Gestão e Economia de Serviços de Saúde
thesis.degree.grantor	Faculdade de Economia
thesis.degree.grantor	Universidade do Porto
thesis.degree.level	1
Appears in Collections:	FEP - Relatório de Projeto

Files in This Item:

File	Description	Size	Format
648919.pdf Restricted Access	Comparative economic impact of intravenous versus subcutaneous administration of rituximab in patients with non-Hodgkin lymphoma	1.18 MB	Adobe PDF	View/Open